POSTN and lethal osteosclerotic bone dysplasia: To verify the interaction between FAM20C and POSTN, a kinase inactive form of FAM20C (D478A) and a Raine-syndrome mutation form (P328S) in addition to FAM20C-WT were used for the binding assay.